We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Cyazofamid Market by Manufacturers, Regions, Type and Application, Forecast to 2027

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Scope of the Report:
This report focuses on the Cyazofamid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
4-methylacetophenone is the main raw materials. Cyazofamid are often applied to treat downy mildew oomycetes diseases.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, which production reached 335 MT in 2016, with the share of 81.91%.
The consumption shares of Japan, China, North America and Europe were 42.79%, 21.52%, 17.11% and 11.74%. Japan is the main import region and other countries need to import from Japan.
The worldwide market for Cyazofamid is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 90 million US$ in 2023, from 82 million US$ in 2017, according to a new WMR study.

Market Segment by Manufacturers, this report covers
ISHIHARA SANGYO KAISHA
Rudong Zhongyi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Type I
Type II

Market Segment by Applications, can be divided into
Downy Mildew
Oomycetes Diseases
Others

There are 15 Chapters to deeply display the global Cyazofamid market.
Chapter 1, to describe Cyazofamid Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cyazofamid, with sales, revenue, and price of Cyazofamid, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cyazofamid, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cyazofamid market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cyazofamid sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview
1.1 Cyazofamid Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Downy Mildew
1.3.2 Oomycetes Diseases
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ISHIHARA SANGYO KAISHA
2.1.1 Business Overview
2.1.2 Cyazofamid Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Rudong Zhongyi
2.2.1 Business Overview
2.2.2 Cyazofamid Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Rudong Zhongyi Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cyazofamid Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cyazofamid Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cyazofamid Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cyazofamid Manufacturer Market Share in 2017
3.3.2 Top 6 Cyazofamid Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cyazofamid Market Analysis by Regions
4.1 Global Cyazofamid Sales, Revenue and Market Share by Regions
4.1.1 Global Cyazofamid Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cyazofamid Revenue and Market Share by Regions (2013-2018)
4.2 North America Cyazofamid Sales and Growth Rate (2013-2018)
4.3 Europe Cyazofamid Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cyazofamid Sales and Growth Rate (2013-2018)
4.5 South America Cyazofamid Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cyazofamid Sales and Growth Rate (2013-2018)
5 North America Cyazofamid by Countries
5.1 North America Cyazofamid Sales, Revenue and Market Share by Countries
5.1.1 North America Cyazofamid Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cyazofamid Revenue and Market Share by Countries (2013-2018)
5.2 United States Cyazofamid Sales and Growth Rate (2013-2018)
5.3 Canada Cyazofamid Sales and Growth Rate (2013-2018)
5.4 Mexico Cyazofamid Sales and Growth Rate (2013-2018)
6 Europe Cyazofamid by Countries
6.1 Europe Cyazofamid Sales, Revenue and Market Share by Countries
6.1.1 Europe Cyazofamid Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cyazofamid Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cyazofamid Sales and Growth Rate (2013-2018)
6.3 UK Cyazofamid Sales and Growth Rate (2013-2018)
6.4 France Cyazofamid Sales and Growth Rate (2013-2018)
6.5 Russia Cyazofamid Sales and Growth Rate (2013-2018)
6.6 Italy Cyazofamid Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cyazofamid by Countries
7.1 Asia-Pacific Cyazofamid Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cyazofamid Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cyazofamid Revenue and Market Share by Countries (2013-2018)
7.2 China Cyazofamid Sales and Growth Rate (2013-2018)
7.3 Japan Cyazofamid Sales and Growth Rate (2013-2018)
7.4 Korea Cyazofamid Sales and Growth Rate (2013-2018)
7.5 India Cyazofamid Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cyazofamid Sales and Growth Rate (2013-2018)
8 South America Cyazofamid by Countries
8.1 South America Cyazofamid Sales, Revenue and Market Share by Countries
8.1.1 South America Cyazofamid Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cyazofamid Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cyazofamid Sales and Growth Rate (2013-2018)
8.3 Argentina Cyazofamid Sales and Growth Rate (2013-2018)
8.4 Colombia Cyazofamid Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cyazofamid by Countries
9.1 Middle East and Africa Cyazofamid Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cyazofamid Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cyazofamid Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cyazofamid Sales and Growth Rate (2013-2018)
9.3 UAE Cyazofamid Sales and Growth Rate (2013-2018)
9.4 Egypt Cyazofamid Sales and Growth Rate (2013-2018)
9.5 Nigeria Cyazofamid Sales and Growth Rate (2013-2018)
9.6 South Africa Cyazofamid Sales and Growth Rate (2013-2018)
10 Global Cyazofamid Market Segment by Type
10.1 Global Cyazofamid Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cyazofamid Sales and Market Share by Type (2013-2018)
10.1.2 Global Cyazofamid Revenue and Market Share by Type (2013-2018)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2013-2018)
10.2.2 Global Type I Price (2013-2018)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2013-2018)
10.3.2 Global Type II Price (2013-2018)
11 Global Cyazofamid Market Segment by Application
11.1 Global Cyazofamid Sales Market Share by Application (2013-2018)
11.2 Downy Mildew Sales Growth (2013-2018)
11.3 Oomycetes Diseases Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Cyazofamid Market Forecast (2018-2023)
12.1 Global Cyazofamid Sales, Revenue and Growth Rate (2018-2023)
12.2 Cyazofamid Market Forecast by Regions (2018-2023)
12.2.1 North America Cyazofamid Market Forecast (2018-2023)
12.2.2 Europe Cyazofamid Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cyazofamid Market Forecast (2018-2023)
12.2.4 South America Cyazofamid Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cyazofamid Market Forecast (2018-2023)
12.3 Cyazofamid Market Forecast by Type (2018-2023)
12.3.1 Global Cyazofamid Sales Forecast by Type (2018-2023)
12.3.2 Global Cyazofamid Market Share Forecast by Type (2018-2023)
12.4 Cyazofamid Market Forecast by Application (2018-2023)
12.4.1 Global Cyazofamid Sales Forecast by Application (2018-2023)
12.4.2 Global Cyazofamid Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Cyazofamid Picture
Table Product Specifications of Cyazofamid
Figure Global Sales Market Share of Cyazofamid by Types in 2017
Table Cyazofamid Types for Major Manufacturers
Figure Type I Picture
Figure Type II Picture
Figure Cyazofamid Sales Market Share by Applications in 2017
Figure Downy Mildew Picture
Figure Oomycetes Diseases Picture
Figure Others Picture
Figure United States Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure France Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure China Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure India Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cyazofamid Revenue (Value) and Growth Rate (2013-2023)
Table ISHIHARA SANGYO KAISHA Basic Information, Manufacturing Base and Competitors
Table ISHIHARA SANGYO KAISHA Cyazofamid Type and Applications
Table ISHIHARA SANGYO KAISHA Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rudong Zhongyi Basic Information, Manufacturing Base and Competitors
Table Rudong Zhongyi Cyazofamid Type and Applications
Table Rudong Zhongyi Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cyazofamid Sales by Manufacturer (2016-2017)
Figure Global Cyazofamid Sales Market Share by Manufacturer in 2016
Figure Global Cyazofamid Sales Market Share by Manufacturer in 2017
Table Global Cyazofamid Revenue by Manufacturer (2016-2017)
Figure Global Cyazofamid Revenue Market Share by Manufacturer in 2016
Figure Global Cyazofamid Revenue Market Share by Manufacturer in 2017
Figure Top 3 Cyazofamid Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cyazofamid Manufacturer (Revenue) Market Share in 2017
Figure Global Cyazofamid Sales and Growth Rate (2013-2018)
Figure Global Cyazofamid Revenue and Growth Rate (2013-2018)
Table Global Cyazofamid Sales by Regions (2013-2018)
Table Global Cyazofamid Sales Market Share by Regions (2013-2018)
Table Global Cyazofamid Revenue by Regions (2013-2018)
Figure Global Cyazofamid Revenue Market Share by Regions in 2013
Figure Global Cyazofamid Revenue Market Share by Regions in 2017
Figure North America Cyazofamid Sales and Growth Rate (2013-2018)
Figure Europe Cyazofamid Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cyazofamid Sales and Growth Rate (2013-2018)
Figure South America Cyazofamid Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cyazofamid Sales and Growth Rate (2013-2018)
Figure North America Cyazofamid Revenue and Growth Rate (2013-2018)
Table North America Cyazofamid Sales by Countries (2013-2018)
Table North America Cyazofamid Sales Market Share by Countries (2013-2018)
Figure North America Cyazofamid Sales Market Share by Countries in 2013
Figure North America Cyazofamid Sales Market Share by Countries in 2017
Table North America Cyazofamid Revenue by Countries (2013-2018)
Table North America Cyazofamid Revenue Market Share by Countries (2013-2018)
Figure North America Cyazofamid Revenue Market Share by Countries in 2013
Figure North America Cyazofamid Revenue Market Share by Countries in 2017
Figure United States Cyazofamid Sales and Growth Rate (2013-2018)
Figure Canada Cyazofamid Sales and Growth Rate (2013-2018)
Figure Mexico Cyazofamid Sales and Growth Rate (2013-2018)
Figure Europe Cyazofamid Revenue and Growth Rate (2013-2018)
Table Europe Cyazofamid Sales by Countries (2013-2018)
Table Europe Cyazofamid Sales Market Share by Countries (2013-2018)
Table Europe Cyazofamid Revenue by Countries (2013-2018)
Figure Europe Cyazofamid Revenue Market Share by Countries in 2016
Figure Europe Cyazofamid Revenue Market Share by Countries in 2017
Figure Germany Cyazofamid Sales and Growth Rate (2013-2018)
Figure UK Cyazofamid Sales and Growth Rate (2013-2018)
Figure France Cyazofamid Sales and Growth Rate (2013-2018)
Figure Russia Cyazofamid Sales and Growth Rate (2013-2018)
Figure Italy Cyazofamid Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cyazofamid Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cyazofamid Sales by Countries (2013-2018)
Table Asia-Pacific Cyazofamid Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cyazofamid Sales Market Share by Countries 2017
Table Asia-Pacific Cyazofamid Revenue by Countries (2013-2018)
Figure Asia-Pacific Cyazofamid Revenue Market Share by Countries 2017
Figure China Cyazofamid Sales and Growth Rate (2013-2018)
Figure Japan Cyazofamid Sales and Growth Rate (2013-2018)
Figure Korea Cyazofamid Sales and Growth Rate (2013-2018)
Figure India Cyazofamid Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cyazofamid Sales and Growth Rate (2013-2018)
Figure South America Cyazofamid Revenue and Growth Rate (2013-2018)
Table South America Cyazofamid Sales by Countries (2013-2018)
Table South America Cyazofamid Sales Market Share by Countries (2013-2018)
Figure South America Cyazofamid Sales Market Share by Countries in 2017
Table South America Cyazofamid Revenue by Countries (2013-2018)
Table South America Cyazofamid Revenue Market Share by Countries (2013-2018)
Figure South America Cyazofamid Revenue Market Share by Countries in 2017
Figure Brazil Cyazofamid Sales and Growth Rate (2013-2018)
Figure Argentina Cyazofamid Sales and Growth Rate (2013-2018)
Figure Colombia Cyazofamid Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cyazofamid Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cyazofamid Sales by Countries (2013-2018)
Table Middle East and Africa Cyazofamid Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cyazofamid Sales Market Share by Countries in 2017
Table Middle East and Africa Cyazofamid Revenue by Countries (2013-2018)
Table Middle East and Africa Cyazofamid Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cyazofamid Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cyazofamid Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cyazofamid Sales and Growth Rate (2013-2018)
Figure UAE Cyazofamid Sales and Growth Rate (2013-2018)
Figure Egypt Cyazofamid Sales and Growth Rate (2013-2018)
Figure Nigeria Cyazofamid Sales and Growth Rate (2013-2018)
Figure South Africa Cyazofamid Sales and Growth Rate (2013-2018)
Table Global Cyazofamid Sales by Type (2013-2018)
Table Global Cyazofamid Sales Share by Type (2013-2018)
Table Global Cyazofamid Revenue by Type (2013-2018)
Table Global Cyazofamid Revenue Share by Type (2013-2018)
Figure Global Type I Sales Growth (2013-2018)
Figure Global Type I Price (2013-2018)
Figure Global Type II Sales Growth (2013-2018)
Figure Global Type II Price (2013-2018)
Table Global Cyazofamid Sales by Application (2013-2018)
Table Global Cyazofamid Sales Share by Application (2013-2018)
Figure Global Oomycetes Diseases Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Cyazofamid Sales, Revenue and Growth Rate (2018-2023)
Table Global Cyazofamid Sales Forecast by Regions (2018-2023)
Table Global Cyazofamid Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cyazofamid Market Forecast (2018-2023)
Figure Europe Sales Cyazofamid Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cyazofamid Market Forecast (2018-2023)
Figure South America Sales Cyazofamid Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cyazofamid Market Forecast (2018-2023)
Table Global Cyazofamid Sales Forecast by Type (2018-2023)
Table Global Cyazofamid Market Share Forecast by Type (2018-2023)
Table Global Cyazofamid Sales Forecast by Application (2018-2023)
Table Global Cyazofamid Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (thousand ton / metric ton / cubic meter).
Market is segmented by:
  • Product Types
  • Applications
  • Technology
  • End-use Industries
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved